Antitumour activity of histamine plus H2-receptor antagonist.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006632:Histamine / Q000008:administration & dosage; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D013274:Stomach Neoplasms / Q000188:drug therapy*
D006635:Histamine H2 Antagonists; D006632:Histamine